Ironwood Pharmaceuticals Net Profit Margin 2009-2020 | IRWD

Ironwood Pharmaceuticals net profit margin from 2009 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Ironwood Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-09-30 $0.40B $0.07B 18.09%
2020-06-30 $0.43B $0.06B 13.85%
2020-03-31 $0.44B $0.05B 10.48%
2019-12-31 $0.43B $0.02B 4.91%
2019-09-30 $0.43B $-0.00B -0.92%
2019-06-30 $0.37B $-0.20B -54.08%
2019-03-31 $0.35B $-0.26B -74.93%
2018-12-31 $0.35B $-0.28B -80.98%
2018-09-30 $0.31B $-0.25B -81.94%
2018-06-30 $0.33B $-0.11B -33.84%
2018-03-31 $0.32B $-0.11B -33.97%
2017-12-31 $0.30B $-0.12B -39.26%
2017-09-30 $0.29B $-0.14B -49.14%
2017-06-30 $0.27B $-0.14B -53.33%
2017-03-31 $0.26B $-0.12B -47.10%
2016-12-31 $0.27B $-0.08B -30.04%
2016-09-30 $0.24B $-0.08B -34.31%
2016-06-30 $0.21B $-0.10B -45.07%
2016-03-31 $0.19B $-0.12B -65.24%
2015-12-31 $0.15B $-0.14B -94.67%
2015-09-30 $0.14B $-0.17B -122.96%
2015-06-30 $0.11B $-0.16B -143.75%
2015-03-31 $0.09B $-0.17B -190.11%
2014-12-31 $0.08B $-0.19B -246.75%
2014-09-30 $0.04B $-0.20B -463.64%
2014-06-30 $0.03B $-0.22B -700.00%
2014-03-31 $0.04B $-0.23B -654.29%
2013-12-31 $0.02B $-0.27B -1186.96%
2013-09-30 $0.05B $-0.27B -588.89%
2013-06-30 $0.14B $-0.16B -113.97%
2013-03-31 $0.14B $-0.13B -92.91%
2012-12-31 $0.15B $-0.07B -48.67%
2012-09-30 $0.16B $-0.04B -23.23%
2012-06-30 $0.07B $-0.11B -147.89%
2012-03-31 $0.07B $-0.08B -123.88%
2011-12-31 $0.07B $-0.07B -100.00%
2011-09-30 $0.05B $-0.07B -140.00%
2011-06-30 $0.05B $-0.06B -121.28%
2011-03-31 $0.05B $-0.06B -122.22%
2010-12-31 $0.04B $-0.05B -120.45%
2010-09-30 $0.03B $-0.07B -191.18%
2010-06-30 $0.04B $-0.07B -170.00%
2010-03-31 $0.04B $-0.07B -181.58%
2009-12-31 $0.03B $-0.07B -208.82%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.894B $0.428B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.741B 41.83
Takeda Pharmaceutical (TAK) Japan $56.655B 10.57
Astellas Pharma (ALPMY) Japan $29.025B 18.13
Eisai (ESALY) Japan $22.465B 19.57
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $20.595B 0.00
Catalent (CTLT) United States $16.042B 47.98
Grifols, S.A (GRFS) Spain $12.850B 14.72
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.500B 23.81
Neurocrine Biosciences (NBIX) United States $8.928B 70.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.448B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.983B 12.90
IPSEN SA ADR (IPSEY) France $7.959B 0.00
Ionis Pharmaceuticals (IONS) United States $7.149B 70.04
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.473B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $6.023B 12.82
Evotec AG (EVTCY) Germany $4.987B 338.89
PTC Therapeutics (PTCT) United States $4.366B 0.00
Sage Therapeutics (SAGE) United States $3.933B 0.00
ChemoCentryx (CCXI) United States $3.863B 0.00
Hypermarcas (HYPMY) Brazil $3.699B 13.60
FibroGen (FGEN) United States $3.656B 0.00
Cronos Group (CRON) Canada $3.017B 0.00
Nektar Therapeutics (NKTR) United States $3.012B 0.00
Revolution Medicines (RVMD) United States $2.919B 0.00
Pacira BioSciences (PCRX) United States $2.772B 60.19
Taro Pharmaceutical Industries (TARO) Israel $2.693B 13.75
Corcept Therapeutics (CORT) United States $2.671B 25.83
Xencor (XNCR) United States $2.456B 0.00
Trillium Therapeutics (TRIL) Canada $1.981B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.844B 0.00
Heron Therapeutics (HRTX) United States $1.634B 0.00
USANA Health Sciences (USNA) United States $1.613B 14.19
Translate Bio (TBIO) United States $1.438B 0.00
Ocular Therapeutix (OCUL) United States $1.244B 0.00
Endo (ENDP) Ireland $1.241B 1.88
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.220B 8.48
Zogenix (ZGNX) United States $1.200B 0.00
Tilray (TLRY) Canada $1.135B 0.00
Indivior (INVVY) United States $1.130B 14.00
Karyopharm Therapeutics (KPTI) United States $1.114B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.050B 0.00
ImmunoGen (IMGN) United States $1.035B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.906B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.861B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.795B 0.00
VAXART, INC (VXRT) United States $0.770B 0.00
Esperion Therapeutics (ESPR) United States $0.753B 0.00
Radius Health (RDUS) United States $0.748B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.690B 0.00
Collegium Pharmaceutical (COLL) United States $0.664B 39.16
BioSpecifics Technologies Corp (BSTC) United States $0.650B 33.91
Aerie Pharmaceuticals (AERI) United States $0.609B 0.00
Chinook Therapeutics (KDNY) United States $0.590B 0.00
Ardelyx (ARDX) United States $0.569B 0.00
Siga Technologies (SIGA) United States $0.548B 15.39
Organogenesis Holdings (ORGO) United States $0.538B 0.00
Flexion Therapeutics (FLXN) United States $0.534B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.526B 0.00
Akebia Therapeutics (AKBA) United States $0.490B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.473B 0.00
Molecular Templates (MTEM) United States $0.456B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.435B 0.00
Innate Pharma SA (IPHYF) France $0.428B 0.00
TherapeuticsMD (TXMD) United States $0.406B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.384B 10.00
Harpoon Therapeutics (HARP) United States $0.377B 0.00
Profound Medical (PROF) Canada $0.373B 0.00
DURECT (DRRX) United States $0.370B 0.00
KalVista Pharmaceuticals (KALV) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.348B 0.00
Altimmune (ALT) United States $0.348B 0.00
Rafael Holdings (RFL) United States $0.346B 0.00
Calithera Biosciences (CALA) United States $0.345B 0.00
MEI Pharma (MEIP) United States $0.340B 0.00
Redhill Biopharma (RDHL) Israel $0.331B 0.00
CASI Pharmaceuticals (CASI) United States $0.300B 0.00
Summit Therapeutics (SMMT) United States $0.292B 0.00
Jounce Therapeutics (JNCE) United States $0.290B 0.00
Menlo Therapeutics (VYNE) United States $0.289B 0.00
CTI BioPharma (CTIC) United States $0.274B 0.00
Lannett Co Inc (LCI) United States $0.266B 7.02
Nature's Sunshine Products (NATR) United States $0.248B 16.00
IMV INC (IMV) Canada $0.241B 0.00
Aquestive Therapeutics (AQST) United States $0.237B 0.00
Alpine Immune Sciences (ALPN) United States $0.234B 0.00
OptiNose (OPTN) United States $0.222B 0.00
Xeris Pharmaceuticals (XERS) United States $0.222B 0.00
Otonomy (OTIC) United States $0.217B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.217B 0.00
Heat Biologics (HTBX) United States $0.182B 0.00
Taiwan Liposome (TLC) Taiwan $0.164B 0.00
Champions Oncology (CSBR) United States $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.142B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.138B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.130B 0.00
Infinity Pharmaceuticals (INFI) United States $0.128B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.126B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.115B 0.00
ProPhase Labs (PRPH) United States $0.107B 0.00
Lipocine (LPCN) United States $0.104B 0.00
MediWound (MDWD) Israel $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.088B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.084B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.081B 0.00
KemPharm (KMPH) United States $0.080B 0.00
Biomerica (BMRA) United States $0.079B 0.00
SCYNEXIS (SCYX) United States $0.074B 0.00
Novan (NOVN) United States $0.071B 0.00
ElectroCore (ECOR) United States $0.067B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.066B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Natural Alternatives (NAII) United States $0.066B 126.44
Entasis Therapeutics Holdings (ETTX) United States $0.062B 0.00
GTx (ONCT) United States $0.060B 0.00
Recro Pharma (REPH) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.058B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 23.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.044B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
Sundial Growers (SNDL) Canada $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.66
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Vical (BBI) United States $0.036B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.029B 0.00
PolarityTE (PTE) United States $0.027B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.017B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Cyanotech (CYAN) United States $0.017B 27.50
Bellicum Pharmaceuticals (BLCM) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.010B 0.00
Shineco (TYHT) China $0.010B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00